These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3195000)

  • 21. [Results of honvan therapy of prostate carcinoma].
    KLETSCHKE HG
    Z Urol; 1959 Oct; 52():615-22. PubMed ID: 14409820
    [No Abstract]   [Full Text] [Related]  

  • 22. Bioavailability, distribution and pharmacokinetics of diethylstilbestrol converted from diethylstilbestrol diphosphate in patients with prostatic cancer.
    Nakamura K
    Hiroshima J Med Sci; 1986 Dec; 35(4):325-38. PubMed ID: 3570844
    [No Abstract]   [Full Text] [Related]  

  • 23. [Direct determination of diethylstilbestrol and its monoconjugates in plasma].
    Oelschläger H; Rothley D; Dunzendorfer U
    Arzneimittelforschung; 1986 Apr; 36(4):759-63. PubMed ID: 3718601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High-dose intravenous diethylstilbestrol diphosphate therapy for hormone refractory prostate cancer].
    Honda M; Umeda H; Yoshida K
    Nihon Rinsho; 1998 Aug; 56(8):2145-9. PubMed ID: 9750524
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical studies on serum lipids in the patients with tumor of the prostate gland. 2nd. Report. Changes of serum lipids and lipoprotein fractions during the treatment of estramustine phosphate disodium, hexestrol and diethylstilbestrol 4, 4-diphosphoric ester for the patients with prostatic cancer (author's transl)].
    Yoshida H; Shimada M
    Nihon Hinyokika Gakkai Zasshi; 1980 Jan; 71(1):59-69. PubMed ID: 6155501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experiences with Honvan therapy in carcinoma of the prostate].
    Joó GD
    Med Welt; 1966 Jan; 1():61-4. PubMed ID: 5942368
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy].
    Heinz A; Meyer WW; Hallwachs O
    Urologe A; 1984 May; 23(3):178-80. PubMed ID: 6377650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Two cases of prostate cancer associated with acute myeloid leukemia presenting as thrombocytopenia during endocrine therapy].
    Matsuura H; Sakurai M; Arima K
    Hinyokika Kiyo; 2003 Feb; 49(2):87-90. PubMed ID: 12696188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endocrinologic therapy of prostatic cancer].
    Nihira H
    Nihon Hinyokika Gakkai Zasshi; 1986 Dec; 77(12):1910-4. PubMed ID: 3586440
    [No Abstract]   [Full Text] [Related]  

  • 31. [Potential antineoplastics. III: N-mustard derivatives of diethylstilbestrol and hexestrol with free phenolic hydroxy groups (author's transl)].
    Hamacher H
    Arch Pharm (Weinheim); 1978 Mar; 311(3):184-95. PubMed ID: 655784
    [No Abstract]   [Full Text] [Related]  

  • 32. Tissue distribution of stilbestrol diphosphate: concentration in prostatic tissue.
    SEGAL SJ; MARBERGER H; FLOCKS RH
    Trans Am Assoc Genitourin Surg; 1958; 50():49-53; discussion 54-5. PubMed ID: 13625341
    [No Abstract]   [Full Text] [Related]  

  • 33. [Scintigraphic control of bone metastases of prostatic cancer treated with cytonal and cyclophosphamide].
    Grossmann J; Weiss M; Deckart H; Raatzsch H
    Radiobiol Radiother (Berl); 1988; 29(6):736-8. PubMed ID: 3253797
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol.
    Tan YL; Pigeon P; Hillard EA; Top S; Plamont MA; Vessières A; McGlinchey MJ; Müller-Bunz H; Jaouen G
    Dalton Trans; 2009 Dec; (48):10871-81. PubMed ID: 20023917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case report of prostate cancer with Paneth cell-like change].
    Soga N; Suzuki R; Komeda Y
    Hinyokika Kiyo; 1995 Nov; 41(11):891-4. PubMed ID: 8533693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of giant prostate cancer].
    Fujimoto Y; Yamaha M; Maeda S; Takeuchi T; Ito Y; Kuriyama M; Ban Y; Nishiura T
    Hinyokika Kiyo; 1984 Jul; 30(7):925-30. PubMed ID: 6542303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estrogen therapy--high-dose intravenous diethylstilbestrol diphosphate therapy for advanced or hormone refractory prostate cancer].
    Nakagawa M
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():199-204. PubMed ID: 12599571
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells.
    Schulz P; Bauer HW; Brade WP; Keller A; Fittler F
    Cancer Res; 1988 May; 48(10):2867-70. PubMed ID: 2834049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug-induced hepatitis during the hormonal treatment of patients with prostatic tumors].
    Ivlev AS; Polunina TE
    Urol Nefrol (Mosk); 1987; (5):65-6. PubMed ID: 3424474
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer.
    Azuma H; Sakamoto T; Kiyama S; Ubai T; Kotake Y; Inamoto T; Takahara K; Nishimura Y; Segawa N; Katsuoka Y
    Am J Clin Oncol; 2008 Apr; 31(2):188-94. PubMed ID: 18391605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.